Health TrialsbyHealthPanel

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

ConditionsMigraineMigraine DiseaseMigraine HeadacheMigraine Headache, With or Without AuraMigraine, Acute
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAin Shams University

About this trial

Caffeine extracted from green tea to abort acute attack of Migraine

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Caffeine (200 mg)

    Drug

    caffeine tablets

  • triptans

    Drug

    Sumatriptan

  • NSAID (Nonsteroidal anti-inflammatory drugs)

    Drug

    Aspirin 250 mg, 81 mg, 75 mg

  • Paracetamol (acetaminophen)

    Drug

    Paracetamol 250 mg

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Caffeine groupExperimental treatment 4 interventions
Group B: Control groupActive comparator 3 interventions

Trial outcomes

Primary outcomes

1

To reduce the severity of migraine attack

using Visual analogue scale

Time frame
Three years

Secondary outcomes

1

To evaluate the effect of oral caffeine in reducing pain associated with acute migraine attacks among patients attending Headache Clinic, Ain Shams University hospital via Visual analogue scale

To assess the pain reduction through visual analogue scale

Time frame
Three year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov
Apply now